Gulf International Bank (UK)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58M Buy
44,762
+15,517
+53% +$1.28M 0.08% 239
2025
Q4
$2.49M Hold
29,245
0.08% 223
2025
Q3
$2.27M Sell
29,245
-597
-2% -$46.6K 0.07% 248
2025
Q2
$2.33M Sell
29,842
-4,451
-13% -$332K 0.08% 227
2025
Q1
$2.48M Sell
34,293
-13,130
-28% -$940K 0.09% 240
2024
Q4
$3.51M Sell
47,423
-501
-1% -$35.1K 0.09% 208
2024
Q3
$3.16M Sell
47,924
-2,126
-4% -$154K 0.08% 231
2024
Q2
$4.62M Sell
50,050
-2,051
-4% -$182K 0.12% 158
2024
Q1
$4.98M Buy
52,101
+292
+0.6% +$24.5K 0.13% 161
2023
Q4
$3.95M Sell
51,809
-5,731
-10% -$399K 0.11% 182
2023
Q3
$3.99M Sell
57,540
-6,405
-10% -$515K 0.11% 176
2023
Q2
$6.03M Sell
63,945
-20,247
-24% -$1.76M 0.15% 130
2023
Q1
$6.96M Sell
84,192
-21,743
-21% -$1.71M 0.15% 137
2022
Q4
$7.9M Sell
105,935
-570
-0.5% -$43.9K 0.14% 152
2022
Q3
$8.8M Sell
106,505
-371
-0.3% -$35.7K 0.17% 124
2022
Q2
$10.3M Buy
106,876
+505
+0.5% +$52.3K 0.18% 112
2022
Q1
$12.5M Hold
106,371
0.19% 103
2021
Q4
$13.8M Sell
106,371
-21,009
-16% -$2.45M 0.19% 103
2021
Q3
$14.4M Sell
127,380
-1,487
-1% -$170K 0.19% 108
2021
Q2
$13.3M Sell
128,867
-110
-0.1% -$10.4K 0.17% 126
2021
Q1
$10.8M Sell
128,977
-15,263
-11% -$1.29M 0.15% 140
2020
Q4
$13.2M Sell
144,240
-7,588
-5% -$629K 0.17% 124
2020
Q3
$12.1M Sell
151,828
-350
-0.2% -$27.3K 0.17% 123
2020
Q2
$10.5M Buy
152,178
+750
+0.5% +$53.3K 0.16% 133
2020
Q1
$9.52M Sell
151,428
-270
-0.2% -$19.5K 0.18% 122
2019
Q4
$11.8M Sell
151,698
-225
-0.1% -$17.6K 0.18% 121
2019
Q3
$11.1M Sell
151,923
-618
-0.4% -$43.4K 0.18% 123
2019
Q2
$9.39M Sell
152,541
-699
-0.5% -$42.3K 0.16% 143
2019
Q1
$9.77M Buy
153,240
+525
+0.3% +$30K 0.17% 131
2018
Q4
$7.8M Sell
152,715
-61,881
-29% -$3.13M 0.15% 147
2018
Q3
$12.5M Buy
214,596
+15,606
+8% +$763K 0.15% 149
2018
Q2
$9.65M Hold
198,990
0.12% 187
2018
Q1
$9.25M Buy
198,990
+1,350
+0.7% +$58.6K 0.12% 194
2017
Q4
$7.42M Hold
197,640
0.09% 233
2017
Q3
$7.2M Hold
197,640
0.1% 236
2017
Q2
$7.79M Buy
197,640
+300
+0.2% +$10.9K 0.11% 208
2017
Q1
$6.19M Buy
197,340
+2,700
+1% +$84.5K 0.09% 249
2016
Q4
$6.08M Hold
194,640
0.09% 242
2016
Q3
$7.82M Hold
194,640
0.13% 188
2016
Q2
$6.47M Hold
194,640
0.11% 219
2016
Q1
$5.72M Buy
194,640
+7,410
+4% +$204K 0.1% 235
2015
Q4
$4.93M Buy
187,230
+5,040
+3% +$131K 0.09% 263
2015
Q3
$4.32M Hold
182,190
0.08% 282
2015
Q2
$4.33M Hold
182,190
0.08% 291
2015
Q1
$4.33M Hold
182,190
0.08% 293
2014
Q4
$3.87M Buy
182,190
+3,060
+2% +$61.5K 0.07% 323
2014
Q3
$3.05M Hold
179,130
0.06% 377
2014
Q2
$2.56M Hold
179,130
0.05% 452
2014
Q1
$2.21M Hold
179,130
0.04% 484
2013
Q4
$1.96M Buy
+179,130
New +$2.02M 0.04% 510

Other funds holding EW

Gulf International Bank (UK)'s EW Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Edwards Lifesciences (EW) stake by 53% in Q1 2026, buying an estimated $1.28M and bringing the position to 44,762 shares worth $3.58M. The position accounts for 0.08% of the portfolio, ranked #239.

Gulf International Bank (UK) first reported a position in EW in Q4 2013 and has held it in 50 quarters since. The position peaked at $14.4M in Q3 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Gulf International Bank (UK) held 44,762 shares of Edwards Lifesciences worth $3.58M as of Q1 2026.
  • Gulf International Bank (UK) bought 15,517 Edwards Lifesciences shares in Q1 2026, an estimated $1.28M.
  • Edwards Lifesciences made up 0.08% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #239 holding.
  • Gulf International Bank (UK) first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 50 quarters since.
  • Gulf International Bank (UK)'s Edwards Lifesciences position peaked at $14.4M in Q3 2021.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.